Last 390.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
CLPL On Other Exchanges
Symbol
Exchange
CLPL is not on other exchanges.
As of 6:05 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

caplin point laboratories (CLPL) Snapshot

Open
378.10
Previous Close
394.60
Day High
400.00
Day Low
378.10
52 Week High
09/16/14 - 555.00
52 Week Low
01/3/14 - 82.75
Market Cap
5.9B
Average Volume 10 Days
13.1K
EPS TTM
17.11
Shares Outstanding
15.1M
EX-Date
12/11/14
P/E TM
22.8x
Dividend
4.00
Dividend Yield
1.02%
Current Stock Chart for CAPLIN POINT LABORATORIES (CLPL)

Related News

No related news articles were found.

caplin point laboratories (CLPL) Related Businessweek News

No Related Businessweek News Found

caplin point laboratories (CLPL) Details

Caplin Point Laboratories Limited manufactures and sells pharmaceutical formulations in India and internationally. Its product portfolio includes analgesic and antipyretic, antacid, anthelmintic, anti-amoebic, anti-bacterials, antibiotic, anti-cold, antihistaminic, anti-diabetic, anti-hypertensive and anti-anginal, anti-malarial, and antirheumatic formulations. The company’s product line also comprises anti-spasmodic, anti-tubercular, anti-viral, bronchodilator, cortisone, cough syrup, diuretic, haematinic, oral rehydration salts, ointments and gels, urinary antibacterial, and vitamin supplements. In addition, it offers novel and special products, biotech and other lyophilized products, effervescent tablets, soft gel capsules, and medical and hospital consumables, as well as provides contract manufacturing services. Further, the company manufactures a range of creams and other external application products. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India.

Founded in 1990

caplin point laboratories (CLPL) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 588.4K
Chief Financial Officer and Company Secretary
Total Annual Compensation: 3.0M
Chief Operating officer
Total Annual Compensation: 1.8M
Whole Time Director, Member of Audit Committe...
Total Annual Compensation: 633.4K
Compensation as of Fiscal Year 2014.

caplin point laboratories (CLPL) Key Developments

Caplin Point Laboratories Limited Approves the Alteration of Articles of Association

Caplin Point Laboratories Limited announced that the annual general meeting of shareholders of the company was held on December 18, 2014, has approved the alteration of Articles of Association pursuant to the provisions of the Companies.

Caplin Point Laboratories Ltd Approves Final Dividend for the Year Ended June 30, 2014

Caplin Point Laboratories Ltd. approved final dividend of INR 4.00 per share of face value INR 10.00 for the year ended June 30, 2014 at the AGM held on December 18, 2014.

Caplin Point Laboratories Ltd, Annual General Meeting, Dec 18, 2014

Caplin Point Laboratories Ltd, Annual General Meeting, Dec 18, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLPL:IN 390.20 INR -4.40

CLPL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLPL.
View Industry Companies
 

Industry Analysis

CLPL

Industry Average

Valuation CLPL Industry Range
Price/Earnings 19.7x
Price/Sales 3.2x
Price/Book 9.7x
Price/Cash Flow 16.9x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAPLIN POINT LABORATORIES, please visit www.caplinpoint.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.